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ABSTRACT
Cardiovascular disease, currently the leading cause of mortality throughout
the developed countries, is mainly caused by atherosclerosis, which is recognized
as a chronic inflammatory disease. Atherosclerotic plaques are characterized by
accumulations of lipid in arterial walls together with infiltration of macrophages.
These macrophages differentiate from monocytes which transform into foam
cells through phagocytizing various forms of lipid, are believed to be the main
component of early atherosclerotic lesions.

Lysophosphatidic acid (LPA), a potent bioactive lipid, regulates a broad range
of cellular functions in various cell types.

In our findings, LPA‐induced

macrophages may enhance the lipid uptake effect in both J774A.1‐mouse
macrophage cell lines and bone‐marrow derived macrophages (BMDMs) in a time
and dose dependent manner.

To date, LPA activated signaling pathways in macrophage and possible
intracellular molecules mediating LPA‐triggered foam cell formation wait to be
explored. According to our results, we found: 1) LPA receptor 2 and 5 were
predominantly expressed than other receptors in macrophages. 2) Protein Kinase
D (PKD) underwent activation both on the Ser744/748 activation loop and auto
phosphorylation site Ser916 from 2 minutes to 5 minutes upon the addition of
LPA. 3) During the early period of LPA treatment, phospho‐ERK, phospho‐JNK and
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phospho‐P38 all showed signs of short term inhibition ‐ which indicates that
MAPK activity had been transiently inhibited in macrophages by LPA. 4) NF‐
kappaB, a key transcriptional regulator in macrophages, showed no obvious
patterns of activation in our investigation through observing that neither IKK nor
IKB units were activated upon LPA induction. And this finding excludes the
possibility that NF‐kappaB pathway is involved in LPA‐induced macrophage
activation. 5) Our northern blot analysis demonstrated that, SR‐B1 and CD36 –
two scavenger receptors that are critical in lipid accumulation of macrophages –
were up‐regulated by LPA.

Collectively, all emerging data leads us to hypothesize that LPA, through its
receptors to activate intracellular pathways, mediates downstream gene
expression level, then expedites foam cell formation, which may contribute to
atherosclerotic lesion formation.
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Chapter1 Introduction
Cardiovascular disease (CVD) is the leading cause of mortality in most
developed countries, which proximately accounts for 16.7 million deaths each year
worldwide [1]. Atherosclerosis – underlies coronary artery disease and is the most
common form of cardiovascular disorders. Currently atherosclerosis is widely
accepted as a slow progressive chronic inflammatory disease, which is
characterized by the formation of atherosclerotic plaques consisting of necrotic
cores, calcified regions, accumulated modified lipids, migrated smooth muscle
cells (SMCs), foam cells, endothelial cells (ECs), and leukocytes [2]. Macrophages
play an important role in plaque formation. Their precursor form ‐ monocytes,
together with platelets and T‐lymphocytes, interact with ECs and SMCs in multiple
ways to contribute to the development of atherosclerotic lesions [3].

Structure of Normal Arteries
Normal arteries have a well‐developed tri‐laminar structure which includes
intima – the innermost layer, media – lies between intima and outer layer of blood
vessels, and adventitia –outermost layer of the artery. The intima layer is crucial in
understanding the pathogenesis of atherosclerosis. Though many studies
described the intima layer as consisting of a single layer of ECs with little
underlying subendothelial connective tissues, the real structure of this layer in
adults shows more complexity and heterogeneity [4]. The major cell type located
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in the media layer is smooth muscle cells, interleaved with layers of elastin‐rich
extracellular matrix. The adventitia layer exhibits a loose array of cells ‐ such as
fibroblasts and mast cells, and receives little attention in atherosclerosis studies
[4].

Inflammation in Atherosclerosis
Based on a strong clinical relationship between hypercholesterolemia and
atheroma, the regulation of cholesterol and low density lipoprotein (LDL) seemed
to be both valuable and dominant in evaluating cardiovascular risk factors during
early investigations [5]. In the 1970s and 1980s, attention migrated to growth
factors and smooth muscles due to an evolving knowledge on vascular biology.
Finally in the past decade, investigations became more and more appreciative of
the prominent role of inflammation in cardiovascular complications [2].
Inflammation has been closely linked with the formation, progression and
rupture of atherosclerotic plaques [6]. Numerous studies show that either various
kinds of inflammatory cytokines or inflammatory cells participate in disease
regulation. The initiation of plaques requires activated endothelial cells to express
adhesion molecules, which attract flowing blood monocytes to the endothelial
layer. Many studies suggest adhesion plays a key role in monocyte/macrophage
recruitment. And these adhesion molecules include VACM‐1, ICAM‐1, P‐selectin
and E‐selectin [7]. After monocytes are recruited beneath the endothelial layer of
the arterial wall, they continue to be stimulated by macrophage colony stimulating
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factor (M‐CSF) and other differentiation stimuli. Then these monocytes are
differentiated into two major types of macrophages – M1 and M2 macrophages
[1]. Fully matured macrophages stably express various kinds of scavenger‐
receptors (SRs), and these receptors are likely to be responsible for accumulating
different forms of LDL. Lipid‐laden macrophages ‐ the so called “foam cells”, then
undergo apoptosis and pile beneath the arterial wall (intima layer). The
suppressed clearance of these apoptotic cells (efferocytosis) leads to the
formation of the early plaques. Subsequently, smooth muscle cells located in the
media migrate into the top intima layer and multiply to produce a tough, fibrous
matrix to glue onto the fatty streak. However, these seemingly tough fibrous caps
can be easily digested by inflammatory cytokines secreted from foam cells. Once
the cap breaks down, blood coagulation initiator – tissue factor released out from
the plaques, will cause the formation of a thrombus. As the clot grows bigger and
bigger, the patient at this stage will experience heart attack or stroke due to the
blockage of blood flow [8].

Macrophage Subtypes during Atherosclerosis
Induced by M‐CSF and GM‐CSF, monocytes can differentiate into two subtypes
– M1 and M2 macrophages. The two type of macrophages play opposite roles
during inflammation and both are present in atherosclerotic lesions. Ly6C is a cell
differentiation antigen regulated by interferon gamma. In mice, monocytes which
express a high level of Ly6C antigen will differentiate into M1 macrophages upon
stimulation, and cells with a low level of Ly6C antigen will differentiate into M2
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macrophages. M1 macrophages ‐ classically activated by IFN‐, produce a high
level of cytokines such as IL‐2, IL‐23, IL‐6, IL‐1 and TNF‐. In contrast, monocytes
with low Ly6C are usually activated in the presence of IL‐4, IL‐13, and IL‐1, and
tend to produce a large amount of IL‐10 and express scavenger receptors. Clinical
evidence suggests that an imbalance of M1 (classically activated) and M2
(alternatively activated) macrophages may have a significant role in advancing
atherosclerosis and impairing resolution in vitro [9]. Although the role of
macrophages in atherosclerosis development has not been fully understood, it is
clear that macrophages participate in several major processes including:
infiltrating into intimal layer, increasing plaque size, pathologically processing
lipids uptake, inhibiting cholesterol efflux to form “foam cells”, and secreting a
broad range of cytokines in response to various stimuli to amplify the
inflammatory process [10].

Scavenger Receptor ‐ mediated Lipid Metabolism
The first scavenger receptors were identified through a combination of uptake
assays using I125‐labeled acetylated LDL, then the work of identification was quickly
extended to a broad range of structurally unrelated molecules [11‐13]. Until 1997,
a detailed framework of scavenger receptors’ classification was brought up by
Krieger and colleagues and is now becomes widely accepted. The proposed
classification encompassed 8 different scavenger receptors from A to H. Most of
which have shown significant roles in atherosclerosis development. (Please see
table I)
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For SR class A (SR‐AI and AII), initial studies on these receptors showed that SR‐
AI and AII knock‐out mice (Msr‐/‐) backcrossed with apoE‐deficient (Apoe‐/‐) mice
showed a significant decrease in aortic sinus atherosclerotic lesions, indicating
that lipid uptake via SR‐A is pro‐atherosclerotic [14]; however, subsequent
investigations of SR‐A failed to support earlier observations – over expression of
SR‐A does not necessarily leads to more atherosclerotic lesion formation[15, 16].
Recent reports suggest that SR‐As, account for the uptake of acetylated LDL
(AcLDL) but not oxidized‐LDL (oxLDL) uptake in a majority of macrophages [14].
Notably, the role played by SR‐As may turn from an earlier pro‐atherosclerotic one
into an athero‐protective one by recent findings that a higher SR‐A expression
level was found in animals with low atherosclerotic response compared to normal
animals with a normal atherosclerotic response [17].
Class B scavenger receptors were identified along with CD36 for up‐taking
oxLDL. Three members were included: SR‐BI, SRBII, and SRBIII(CD36). Different
from the SR‐A family, CD 36 as a type III receptor which only shows 30% homology
with the other two members in this family (SR‐BI, SRBII), and traverses twice in cell
membrane to form a heavily glycosylated extracellular loop with 2 short
intracellular tails. Studies by Moore and Freeman’s group and others indicate that
CD 36 rather than SR‐A played a major role in clearance the cholesterol from the
body: contributing 60%‐70% of cholesterol ester accumulation in macrophages
when exposed to copper oxidized LDL [18‐20]. Along with recent findings, CD36
activates signaling via TLR2 and TLR6 in response to lipoteichoic acid and
diacylated macrophage‐activity [21].
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LOX‐1 was identified as scavenger receptor class E, a lectin‐like, type II
transmembrane protein [22]. LOX‐1 is also expressed on the macrophage cell
surface and is a potential receptor for phagocytizing oxLDL, recent research
suggests that overexpression of LOX‐1 in Apoe‐/‐ mice enhances oxLDL uptake and
accelerates intramyocardial vasculopathology[23]. However, the role of LOX‐1 in
the development of atherosclerosis still needs further confirmation and
investigation.

Lysophosphatidic acid (LPA): Function, Receptors and Implication in
Atherosclerosis
Lysophosphatidic acid (LPA; 1‐acyl 2‐hydroxyl glycerol 3‐phosphate) is a bioactive
lipid component with multiple biological functions by regulating a variety of
diseases[24]. The earliest study of LPA’s physiological role traced back to 1963 by
Vogt[25]. After which, Tokumura and colleagues applied an animal model to prove
that LPA exerts a strong physiological role in affecting the function of blood vessels
in vivo[26]. Schumucher and Gerrard in 1979 discovered that LPA could stimulate
platelets aggregation which was considered as among the first recognition of LPA
function in thrombotic vascular disease [27, 28].Recently, Chun’s group and others
found at least five LPA receptors (LPA1‐5), that links to multiple downstream
effector pathways. By using these receptor‐deletion mouse models, recent studies
on LPA biological and physiological functions shed new light on the subject.
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LPA1 is the most widely expressed receptor in a variety of organs and tissues:
brain, colon, small intestine, placenta, and heart etc. LPA2 and LPA3 showed a
more narrow expression map compared to LPA1. In mice, LPA2 expression is found
to be most abundant in embryonic brain, kidney, and testis; LPA3 expression is
restricted to lung, kidney and testis. LPA4 and LPA5 has not been fully explored and
understood. Significant expression of LPA4 has only been observed in the ovary
[29]. LPA5 has a broad, low level expression over many tissues and organs[30].

Oxidized LDL is one of the most likely contributors in the pathological process
of atherosclerosis and thrombosis. As LPA has been found to be formed during
mild oxidation of LDL and the active compound in various forms of oxidized LDL, it
may play an important role in the development of atherosclerosis and thrombosis.
Although no severe vascular defects have been reported from single deletion of
LPA receptors in animal models, the importance of LPA has never been neglected
by these years’ publications. It has been shown that, LPA induces the expression
adhesion molecules, which include E‐selectin, VCAM‐1 and ICAM‐1 in ECs [31‐33].
In smooth muscle cells, our previous data suggest that LPA has a strong effect in
promoting smooth muscle cells proliferation and migration, a central step in
atherosclerotic lesion development. In monocytes and macrophages, LPA either
directly or indirectly modulates monocytic cell migration via up‐regulating
secretion of MCP‐1 and IL‐8 from ECs [34, 35]. Our study intended to prove that
LPA induces oxidized LDL uptake by using multi‐sourced murine macrophages, and
also focused on investigating how LPA activates macrophages and what possible
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mechanisms are involved in this process. The increased uptake of lipids eventually
leads to expedition of foam cell formation – a major component of atherosclerotic
lesion.
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Chapter2 Experimental Methods and Materials
Cell Culture
J774A.1 (mouse macrophage cell line) and L929 (mouse fibroblast) cells were
purchased from ATCC (American Type Culture Collection, Manassas, VA, U.S.A.).
Mouse aorta smooth muscle cells (MASMCs) were prepared from explants of
excised aortas [36]. Bone‐marrow derived macrophages (BMDMs) were harvested
from the femur section of C57B/6 mice (Jackson Laboratory, Bar Harbor, Maine,
U.S.A.). After four consecutive days’ culture in lymphocyte medium, greater than
95% of bone‐marrow progenitor cells were differentiated into macrophages [37].
Lymphocyte medium was acquired by adding 10% L929 conditioned medium into
DMEM (Lonza, Walkersville, MD, U.S.A.) culture medium. While the L929
conditioned medium was prepared by collecting the supernatant out from DMEM
cultured L929 cells and filtering through a 0.22M filter (Millipore, Billerica, MA,
U.S.A.). Mouse peritoneal macrophages (Peri‐M) were collected according to
previous reports[37]. Three percent Brewer thioglycolate medium (BD Biosciences,
Sparks, MD, U.S.A.) was delivered into 6‐8 week old C57B/6 mice by intra‐
peritoneal injection on day 0. After 4 days, the mice were euthanized and their
abdominal section were flushed with 5 to 7ml ice‐cold PBS to harvest the cells. The
cells were firstly culture in regular DMEM medium for 2 hours, and then the
supernatant was removed leaving the cells attached to the bottom of the dish for
experimental purposes.
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Immunofluorescence Staining
Two specific macrophage antibodies were applied for phenotypic identification ‐
rat‐anti‐mouse CD11b and rat‐anti‐mouse F4/80 (AbD Serotec, Raleigh, NC, U.S.A.).
Three different types of cells were included: J774A.1 (positive control), mouse
SMCs (negative control) and bone‐marrow derived macrophages. Cells were
plated on microscope cover glasses (Fisher Scientific, Loughborough, U.K.) in 12‐
well plates (Corning, NY, U.S.A.), fixed with 4% ice‐cold paraformaldehyde (Sigma
Aldrich, St. Louis, MO, U.S.A.) at room temperature for 30 minutes, blocked
against 5% goat serum (Invitrogen, Camarillo, CA, U.S.A.) plus 0.1% Tween‐
20(Sigma Aldrich, St. Louis, MO, U.S.A.) in PBS for 1 hour, then tested against two
antibodies above accordingly, followed by the goat anti‐rat IgG (Alexa‐Fluro 488
labeling) (Invitrogen, Camarillo, CA, U.S.A.) for 2 hours at room temperature. Then
each well was washed with PBST 4 times (5 minutes each) at room temperature;
followed by 2 minutes incubation with DAPI (Invitrogen, Camarillo, CA, U.S.A.).
Finally, the cover glasses were mounted with permanent aqueous mounting
medium (Biogenex, Fremont, CA, U.S.A.) and observed under the microscope.
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Flow Cytometric Analysis
Both J774A.1 and bone marrow derived macrophages were plated in 30mm
culture dishes (Corning, NY, U.S.A.), pretreated with LPA (1‐Acy‐2‐hydeoxy‐sn‐
glycerol‐3‐phosphate, Avanti Polar Lipids Alabaster, Alabama, U.S.A.) and
incubated for various time points with DiI‐labled oxidized LDL (Biomedical
Technologies, Inc. Stoughton, MA, U.S.A.). After two ice‐cold PBS washes, the cells
were detached from dishes through trypsinization. The cells were suspended in
1ml ice‐cold PBS, followed by analysis with an Epics XL‐MCL Flow Cytometer
(Beckman, Brea, CA, U.S.A.). THe excitation wavelength was at 488 nm and the
emitted red fluorescence (FL2) was collected using a 530nm band pass filter.

Oil‐red O Staining
Mwere plated on microscope cover glasses in 12 well plates, after LPA
pretreatment, the cells were incubated with copper oxidized LDL (Biomedical
Technologies, Inc. Stoughton, MA, U.S.A.) at 37 degrees in 5% CO2, and observed
under a microscope after oil‐red O staining. Cells were rinsed twice with PBS, and
then 10% formalin 30minutes was added for fixation. This was followed by four
washes in ice‐cold PBS. Each sample was incubated with 0.75ml Oil‐red O working
solution for 5 minutes at room temperature. Oil‐red O was removed by rinsing
under tap water until the water rinse off clear. Then 0.75ml hematoxylin (Sigma
Aldrich, St. Louis, MO, U.S.A.) was added for 1minute at room temperature and
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rinsed off under tap water. Last, the cover glass was mounted with permanent
aqueous mounting medium (Biogenex, Fremont, CA, U.S.A.) and observed
microscopically.

Northern Blot
Total RNA was extracted from cells in accordance with the manufacturer’s
instructions (Qiagen, Gaithersburg, MD, U.S.A.) and subjected to denaturing
electrophoresis in formaldehyde/ agrose gels. After the sample blotted onto
hybond‐N (Amersham GE healthcare, Pittsburgh,PA) membranes, they were
hybridized with 32P‐labled cDNA probes over night at 65oC. The membranes were
washed twice for 15 minutes each with washing buffer prior to final detection.
The primer pairs used here are showed in table C. Primers were designed to
produce probes around 800bp in length. In order to confirm the probe specificity,
each included one unique restriction enzyme cutting site. Probe testing was
performed before northern hybridization. Amplified DNA fragments were separate
on 1.0% agarose gel and target fragments were recollected using a DNA
purification kit (Qiagen, Gaithersburg, MD, U.S.A.). Purified DNA fragments were
incubated with matched restriction cutting enzymes and buffer at 37oC over‐night.
Gel electrophoresis was used to check the length of each cut fragment to confirm
that it matched our original design.
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Western Blot
Cells were collected at various times following LPA treatment, rinsed with ice‐
cold PBS and lysed in PARP buffer [50 mM Tris ∙ HCl (pH 6.8), 8 M urea, 5% ‐
mercaptoethanol, 2% SDS, and protease inhibitors]. The lysate was sonicated at
4oC for 30 seconds. Samples were boiled with SDS‐PAGE loading buffer (5X) for 10
minutes. An equal portion of lysates were quantified using Bio‐photometer
(Eppendorf, NY, U.S.A.) and samples were separated by 10% SDS‐PAGE and
transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, U.S.A.).
The membranes were then probed with specific antibodies, and reactive bands
were visualized using ECL‐Plus (GE Healthcare).

Conventional PCR
The level of expression of the LPA receptor gene was measured using
conventional Reverse‐transcript PCR. Total RNA was extracted using Trizol
(Invitrogen, Camarillo, CA, U.S.A.). The first strand of DNA was reverse transcribed
using the Thermo Script Reverse Transcript system (Invitrogen, Camarillo, CA,
U.S.A.). Then the cDNA was amplified with target primers using the following
conditions: 5 minutes at 94oC; various repetitive cycles based on experimental
needs for 30 seconds at 94oC, 30 seconds at 58oC, 45seconds at 72oC; and a final
extension for 10 minutes at 72oC. The primer pairs are described in table II.
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RT‐PCR
The expression of mRNA was evaluated by real time PCR. Total RNA was isolated
from J774A.1 cells using an RNeasy mini‐prep kit (Qiagen, Gaithersburg, MD,
U.S.A.). The first strand of cDNA was reverse transcribed using the Thermo Script
Reverse Transcript system (Invitrogen, Camarillo, CA, U.S.A.). Then the cDNA
products were amplified with primers using SYBR Green Master Mix (Invitrogen,
Camarillo, CA, U.S.A.). The amplification conditions went as follows: 2 minutes at
50oC; 10 minutes at 95oC; 40 cycles of 15 seconds at 95oC, 45seconds at 60oC; 15
seconds at 95oC; finally 15 seconds at 60oC. The primer pairs are showed in table II.

Data Analysis
All data were representative of a minimum of three experiments. Results were
expressed as means ±S.D. (Standard Deviation) Comparisons between multiple
groups were performed using one‐way ANOVA with Dunnett’s post hoc t‐tests. A
single comparison analysis was made using two‐tailed unpaired Student t‐tests. P
values of ±0.05 for ANOVA or t‐tests were considered to be statistically significant.
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Chapter3 Results
1. Macrophage Characteristic Exploration
Macrophage Phenotypic Identification

In order to characterize the phenotypic characteristics of macrophages from
multiple sources in our experiments, we used macrophage specific markers CD11b
and F4/80 for phenotypic identification of three cell lines: The J774A.1
macrophage cell line was purchased from ATCC, Bone‐marrow derived
macrophages (BMDM) were isolated from mouse femurs, smooth muscle cells
(SMCs)

were

isolated

from

mouse

aorta.

As

demonstrated

in

the

immunofluorescence data below (Fig.1) about 95% of the BMDM cell population
were positively stained by the two markers compared to J774A.1 macrophages
which served as a positive control. SMC, used as a negative control, exhibited no
positive staining. This result suggested that isolated bone‐marrow highly enriched
for macrophages (95% purity level).

‐ 15 ‐

Comparison of LPA Receptor Expression Levels in J774A.1 Macrophages and SMC

LPA stimulates a plethora of different cellular responses through the activation
of its family of cognate G protein coupled receptors. In order to understand which
of the LPA receptors mediates LPA signaling pathway in macrophages, we
performed RT‐PCR and real‐time PCR analyses to evaluate LPA receptor expression
levels. The expression of LPA receptors in macrophages was compared with that in
SMC. The summary of our PCR and real‐time PCR results are shown in Fig. 2‐3. The
LPA1‐5 showed a heterogeneous expression pattern between two cell lines. For
smooth muscle cells (included as a quality control), LPA1, LPA2, LPA4 are
dominantly expressed compared to LPA3 and LPA5. While in the J774A.1
macrophage cell line, only LPA2 and LPA5 are dominantly expressed on the cell
surface. These data suggests that LPA2 and LPA5 may play important role in
mediating LPA induced macrophage activation and function.

‐ 16 ‐

Figure 1 Phenotypic Identification
Macrophage specific markers were examined in three different cell lines. Cells were cultured on cover glass for at
least 12 hours, then fixed with 4% paraformaldehyde. Incubated with CD11b or F4/80 followed by Goat anti Rat
Alex‐fluro 488, DAPI was added to stain the nuclear(Blue). (200X magnification).
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Figure 2 Reverse‐transcript PCR Amplification
Total mRNA was extracted from J774A.1 m cells and SMCs, cDNA was obtained using the Invitrogen Thermo
Reverse Transcript system. The oligo primers are described in table II.
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Figure 3 Real‐time PCR Analysis
Oligo primers were designed to aaccommodatee real time anaalysis. Real‐tim
me PCR primerrs are describeed in table II,
uantify the am
mplification pro
oducts. Resultts were standaardized for comparison.
SYBR Green dye waas added to qu
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2. LPA Enhances Macrophage Lipid Uptake Activity
Although Chang and others first reported that LPA would potentially induce
oxLDL uptake in J774A.1 macrophage [38]; specific signaling cascades and the
intracellular regulatory molecules involved in LPA induced foam cell formation are
still unclear. The following questions are waiting for answers. 1) Which LPA
receptors are involved? 2) Whether LPA elicits cellular protein kinase activation or
whether the specific kinase activation leads to LPA‐induced cellular activity? 3)
Which genes regulated by LPA may contribute to LPA‐induced lipid uptake in
macrophages?

LPA Induces Macrophage DiI‐oxLDL Uptake

Accumulation of oxLDL beneath arterial walls has been viewed as one of the
initial risk factors for fatty streak formation [39]. In order to determine whether
LPA plays a role in macrophage lipid uptake activity, we examined LPA’s effect on
macrophage uptake, J774A.1 were treated with 5M LPA together with 15g/mL
DiI‐oxLDL for 3 hours, then these cells were analyzed using flow cytometry to
quantify the macrophage uptake activity. From the results below (Fig.4), we found
that LPA significantly increases DiI‐oxLDL uptake by J774A.1 macrophages.
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LPA Induced ox‐LDL Uptake in Macrophages in Both Time‐dependent and Dose‐
dependent Manner

DiI (DiIC18) is a fluorescent lipophilic cationic indocarbocyanine dye that can be
used to quantify oxidized LDL. In order to explore how LPA influences oxLDL
uptake, we performed dose response (Fig.5 and Fig.7) and time course
experiments (Fig.6 and Fig.7) in three different macrophage cell lines. Our data
shown that 5M is the optimal concentration for LPA to gain the maximum uptake
effect, indicating that LPA‐induced oxLDL‐uptake effect is dose‐dependent. In time
course analysis, J774A.1 and BMDM showed similar peak uptakes times when LPA
and DiI‐oxLDL were added simultaneously. For peritoneal macrophages, however,
the highest fluorescence intensity occurred at 2 hours LPA pre‐treatment followed
by 3 hours co‐treatment with DiI‐oxLDL. The inconsistency may be due to cell
heterogeneity: peritoneal macrophages isolated from mouse abdominal sections
showed less than 70% purity in macrophage population.
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Figure 4 Flow Cytometric Analysis of LPA‐induced Lipid Uptake in Macrophages.
J774A.1 macrophages were starved for 24hours, then were treated with 5M LPA and 15g/ml DiI‐oxLDL for 3
hours. The horizontal axis in the left histogram represents the fluorescence intensity of DiI dye and the vertical axis
indicates the cell quantity. The bar plot on the right showed the results of the LPA‐induced uptake effect. The mean
intensity value ± SD is shown. **p<0.01
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Figure 5 Dose‐dep
pendent Effeect of LPA‐induced oxLDLL Uptake in M
Macrophagees.
Flow cytometry
c
anaalysis was perfformed to dettermine the LP
PA effect on o
oxLDL uptake in three differeent macrophaage
cell lin
nes. Macrophaage cells weree starved for 2
24 hours beforre treatment, then were treeated with varrious
conceentration of LP
PA and DiI‐oxLLDL at 15g/m
ml simultaneou
usly for 3 hourrs incubation, cells were theen suspended in
1X PBS for analysis..
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Figure 6 LPA‐indu
uced oxLDL U
Uptake in Macrophages in a Time‐de
ependent Maanner.
Flow cytometric
c
analysis was perrformed for th
hree different sources of maacrophages. They were starrved for 24
hours, then treated
d at the indicated time with 5M LPA followed by 3 hours incubation
n with 15g/m
ml DiI‐oxLDL .
were then susspended in 1X PBS for analyysis.
Cells w
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Figure 7 Dose and Time Depeendent Uptake Assay.
Cells p
plated on glass cover slips w
were starved ffor 24 hours, aand then treatted at indicateed time or con
ncentration of
LPA. C
Cells positively stained were quantified in
n two plots an
nd analyzed ussing student’s t‐test.
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3. LPA Triggers the Inhibition of MAPKs
It is well known that macrophages are key components in the inflammatory
process of atherosclerosis, and macrophages are the first inflammatory cells to
invade atherosclerotic lesions [1]. Mitogen‐activated protein kinases (MAPKs) are
serine/threonine protein kinases which regulate a series of cellular functions
including cell proliferation, survival, death, and inflammation. The major three
members of MAPKs are: ERKs, JNKs and p38s. They are regulated through a
phosphorylation cascade. We sought to explore whether the MAPK pathway was
involved in LPA‐induced cellular activity of macrophages, and whether MAPK
pathway contributed to the lipid uptake in macrophages. To get a broad view of
kinase activation, we examined MAPK activity through a complete time course by
applying two sources of macrophage cells, bone‐marrow derived macrophages
and the J774A.1 cell line. Cells were starved for 24 hours prior to LPA treatment.
LPA induction of MAPK activity in SMCs served as a positive control. We observed
an interesting phenomenon that at the very early time points (around 2 to 15
minutes) of LPA stimulation, the activities of MAPK families were inhibited in both
J774A.1 and BMDMs (Fig. 8). To date, LPA induction of MAPK activation in various
cell types has been well documented. Our group showed that LPA induced MAPK
activation in SMCs [40]. The discovery of inhibitory effects of LPA on MAPK
activation in macrophages may present the first evidence of LPA‐stimulated MAPK
inhibition. The inhibitory effect of intracellular MAPKs may influence macrophage
cellular function in response to LPA stimulation.
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Figure 8 MAPK Inhibition in LPA‐induced Macrophages.
This figure shows a temporary inhibition of p‐ERK, p‐JNK and p‐38 in J774A.1 cells (upper panel) and bone‐marrow
derived macrophages (middle panel). In contrast to smooth muscle cells (lower panel), macrophages showed LPA‐
induced dynamic activation of p‐ERK, p‐JNK and p‐p38. All cells were starved over night, after treatment with LPA
for various time periods. Cells were collected and cell lysates were separated in 10% SDS‐PAGE gels and detected in
western blots with specific antibodies.
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4. LPA Induces Protein Kinase D (PKD) Activation
Protein kinase D (PKD), occupies a unique position in early signal transduction
pathways initiated by DAG, which elicits cellular responses through a variety of
effectors [41]. The PKD family consists of three isoforms: PKD1, PKD2 and PKD3.
This protein kinase family is also calcium/calmodulin‐dependent protein kinase
group of serine/threonine kinases [42] . We sought to examine whether PKD is
activated in LPA‐stimulated macrophages and whether PKD activity induced by
LPA is effective on lipid uptake in macrophages. We first detected the expression
of PKD isoforms in macrophages using specific PKD1, PKD2 and PKD3 antibodies.
We found that all three PKD isoforms were expressed in macrophages (Fig.9).
Next, we examined LPA‐induced PKD activation and the dynamics of PKD
phosphorylation in two sources of macrophages. As shown in Fig.10, both PKD1
activation site (Ser916) and PKD1/2 activation loop (Ser744/748) were
phosphorylated in the early time periods in LPA‐induced J774A.1 and BMDMs. The
function of PKD in macrophages has not been determined. Our data suggest the
possibility that activation of PKD may contribute to LPA‐induced lipid uptake in
macrophages.
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Figure 9 Expression Levels of Three PKD Isoforms in J774 A.1 Macrophages.
Cells were starved over‐night and collected without any treatment. Western blot analysis showed that all three
isoforms of PKD are present in J774A.1 macrophages. The molecular weights of the three PKD isoforms are as
follows: PKD1 is 115 kD, PKD2 is 105 kD, PKD3 is 100 kD.

Figure 10 PKD Phosphorylation in LPA‐induced J774A.1 and BMDMs.
All samples were starved over‐night. Cell lysates were collected at various time points after LPA treatment,. Both
916 and 744/748 PKD were phosphorylated by LPA stimulation, PKD1 and PKD3 in served as loading controls.
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5. LPA Up‐regulates the Expression of Macrophage Scavenger Receptors

Classically, scavenger receptor class As and Bs have been considered to be
major factors responsible for cholesterol accumulation in macrophages [1]. Three
members are included in the Class A scavenger receptor family: SR‐AI, SR‐AII and
SR‐AIII. SR‐AI which is dominantly expressed in mouse macrophages, accounts for
80% of modified LDL uptake[10]. In the Class B family, both SR‐BI and CD36 are
crucial for oxidized LDL metabolism in macrophages. Thus, we examined LPA‐
induced macrophage scavenger receptor mRNA expression using Northern blot
analysis. Target probes designed around 800bp were used. Cells were starved for
16 hours prior to LPA stimulation. Total mRNA samples were collected at various
time points after LPA treatment. Our data showed that both CD36 and SR‐BI
mRNA expression level were up‐regulated in response to LPA in a time‐dependent
manner, while SR‐AI remained at pre‐stimulation levels (Fig.12). The results
strongly suggest that the augmenting lipid uptake by LPA may be mediated
through up‐regulation of SR‐B1 and CD36 but not SR‐AI.
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Figure 11 Probe Testing using Restriction Enzyme Cutting.
Four unique site restriction enzymes were applied to PCR products of four scavenger receptors. The length of four
restriction fragments should be: SR‐B1 (666bp,223bp EcorRI); CD36 (508bp,383bp BbsI); LOX‐1 (824bp,35bp MslII);
SR‐A1 (529bp,398bp PstI).

Figure 12 Northern Blot Analysis for Scavenger Receptor mRNA Expression Level.
Cells were starved for over‐night before adding LPA. First‐strand cDNA was acquired using a thermo‐script reverse
transcription kit. The results were quantified by densitometry and reflected histogram to the right.
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6. NF‐B Pathway is NOT Involved in LPA‐induced Macrophage Activation

The intracellular NF‐kappa B pathway has been established for at least a half
century. As a pro‐inflammatory nuclear transcription factor, NF‐B regulates
inflammatory responses in a variety of cell types. In 1996, NF‐kappa B activation
was found in human atherosclerotic lesions and NF‐kappa B activation was
detected in smooth muscle cells, macrophages and endothelial cells [43]. Years
later, NF‐B was found to be activated by hypercholesterolemia in the vessel walls
of a pig model for atherosclerosis [44]. These findings link the NF‐B transcription
pathway to pathogenesis of cardiovascular disease.
NF‐kappa B is a general term referring to a family of transcription factors which
consists of 5 members: p65 (RelA), c‐Rel, RelB, NF‐B1 (p50 and its precursor
protein p105), NF‐B2 (p52 and its precursor p100). These proteins can be folded
into various complexes of homodimers or heterdimers. The most common form,
p65/p50 is widely referred as NF‐B. In this canonical pathway, the activation of
NF‐B requires the phosphorylation of IkB by IKK complex; which is also an
essential step for NF‐B activation cascade. The process for NF‐B activation
begins with the binding of a ligand to a cell surface receptor (TNF Receptor, G‐
coupled Receptor or Toll‐like Receptor, etc), and in turn, these adaptors often
recruit an IKK complex (and catalytic subunits). Activated IKK then
phosphorylates IKB at two serine residues, which leads to its K48 ubiquitination
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and degradation by the proteasome. NF‐B then enters the nucleus to stimulate
the transcription of target genes.
The LPA‐induced NF‐B pathway has been reported recently [33, 45]. However,
whether LPA triggers NF‐B activation in macrophages is unknown. We examined
whether NF‐B is activated by LPA in macrophages using Western blot analysis.
Cells were starved for 24 hours before LPA addition. Cell lysate were protected
against

protein

degradation

and

dephosphorylation

by

adding

protease/phosphatase inhibitors in the lysis buffer. After sonication, lysates were
separated by 10% SDS‐PAGE gels and transferred onto PVDF membranes for
antibody incubation. We observed no phosphorylation of IKK, IKK, IKK, IKB,
and IKB.Also, no obvious phosphorylation occurred either on IKK and IKB unit.
These data indicate that NF‐B is not involved in LPA‐induced macrophage
activation (Fig.13).
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Figure 13 NF‐B pathway Detection in LPA‐induced J774A.1 Macrophages.
Time course of NF‐B phosphorylation in J774A.1 macrophages is shown. IKK and IKB alpha phosphorylation levels
are the two most important indicators of NF‐B activation.
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Chapter4 Discussion
Atherosclerosis, a chronic inflammatory cardiovascular disease, is characterized
by the accumulation of lipids, macrophages, smooth muscle cells, leukocytes and
fibrous tissues at the inner most layers (intima) of the arterial wall.
Lysophosphatidic

acid,

a

bioactive

phospholipid,

accumulates

in

high

concentrations in atherosclerotic lesions. Recent investigations established solid
evidences for LPA in promoting cardiovascular disease progression: LPA induced
smooth muscle cells proliferation and migration and also induced macrophages
and endothelial cells to secret a variety of inflammatory cytokines and adhesion
molecules[4]. Moreover, an in vivo study showed that LPA could potentially lead to
hypertension and neo‐intima formation in animal models, or expedite plaque
formation in a mouse atherosclerosis model. All evidence to date indicates the
crucial roles of LPA in cardiovascular disease.
Macrophages, one of the most important immune effector cells, serve as body
guards in the human body. Recent findings suggest that the accumulation of
cholesterol‐laden macrophages in the intima layer of the arterial wall is the
hallmark of early plaque formation. Understanding the mechanism of cellular
response involved in macrophages is crucial to unveiling the progression of
cardiovascular disease. Although LPA induced smooth muscle cell activation has
been widely reported and explored, the links between LPA and macrophages were
barely established and detailed mechanisms were rarely reported.
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Therefore, it is important to investigate the physiological and pathological role
of LPA in blood monocyte differentiated macrophages. Three different sources of
cells were used in our study, including the J774A.1 cell line purchased from ATCC,
BMDMs isolated from mouse femurs, and peritoneal macrophages isolated from
thioglycolate‐elicited mouse abdominal cavities. However, after a few experiments
we found that only J774A.1 and BMDMs are stable macrophages with a high purity
level, while peritoneal macrophages only showed less than 70% purity in
macrophage population. Thus, we decided to use BMDMs and J774A.1 in our
subsequent experiments. Through the uptake assays in both BMDMs and J774A.1
cells, our data showed an obvious increase in lipid accumulation in LPA treated
macrophages compared to LPA only (negative control) and ox‐LDL only (positive
control) groups. We further showed that LPA‐induced lipid uptake in macrophages
is both time and dose dependent. In order to confirm our results from flow
cytometric analysis, we used a varity of approaches such as Oil‐red O staining and
fluorescent microscopy. Our results indicate that LPA enhances lipid uptake in
macrophage foam cell formation.
Recent studies on LPA‐induced macrophage activities offer a promising
direction toward understanding the indispensable roles of macrophages in
cardiovascular disease: LPA enhances LPS‐induced CXCL16 expression and T‐
lymphocyte migration[46] and LPA induces interleukin‐1beta expression in
macrophages[47]. However, a detailed receptor‐related cell signaling pathway is
still unclear and failed to be addressed in those reports. Our Western blot data
clearly indicates that upon treatment with LPA, both BMDMs and J774A.1
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macrophages exhibited an unexpected, transient inhibitory/deactivated pattern of
MAPK activation. Though current knowledge seems to be far from fully explaining
this phenomenon, the importance of MAPKs in the cellular inflammatory response
reminds us that the properties of LPA‐induced macrophages are totally different
from other LPA‐induced cell models ‐ which promote inflammation through
activating MAPK. Also, macrophages had a very high background of MAPK
activation compared to vascular SMCs that showed an inducible response to LPA
stimulation.
As part of our efforts to better understand the LPA‐triggered signaling pathway
in macrophages, we also examined some other related signal activation pathways
such as PKD and NF‐B. Previously our group identified that PKC and PKD were
involved in LPA and growth factor induced smooth muscle cell and endothelial cell
activation [40, 48, 49]. With similar motifs in classic and novel PKC isoforms, PKD
shows its cysteine‐rich, zinc finger‐like N‐terminal regulatory domain, which binds
to DAG allowing many early cellular response to be activated. Phosphorylation of
PKD1 (Ser916) and phosphorylation of PKD activation loop (Ser744/748) were
established signs of PKD family kinase activation. Our results showed a significant
PKD activation from 2 to 5 minutes in response to LPA in both J774A.1 and BMDM.
To date, there is no report revealing these findings of LPA induction of PKD
activation in macrophages. Our data also indicate that all three PKD isoforms are
present in J774A.1 macrophages. In some cases, PKD is upstream of MAPK and the
activation of PKD could provide insights toward explaining our earlier results on
inhibited activation of MAPK.
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Reportedly, NF‐B is a key player in the inflammatory process of activated
macrophages [50, 51]; however, our results revealed that LPA did not induce the
activation of NF‐B. No phosphorylation was observed on either IKKsubunits
or IKB. These data supports the notion that NF‐B pathway is not involved in
LPA‐induced macrophage activation.
Another interesting finding was that the mRNA expression level of scavenger
receptors – CD36 and SR‐BI, are dramatically increased upon the induction of LPA
in BMDMs. Though the function of scavenger receptors are diverse: mediating
lipid accumulation and cholesterol efflux[52]; promoting inflammatory response
[53] and cell migration[54] and enhancing adhesion molecule secretion[55]. Here
we focused on the role of lipid accumulation in macrophages. Building upon
previous results that showed LPA could expedite/enhance oxLDL uptake in the
presence of LPA, the northern blot analysis on four different scavenger receptors
was done in order to identify whether the mRNA expression level of these
receptors changed over time during LPA treatment. As a result, we found that
CD36 and SR‐B1 are strongly induced upon LPA treatment in a time‐dependent
manner. Meanwhile, our densitometry quantification ruled out the possibility that
SRA1 and LOX‐1 were involved in LPA activation of macrophages.
In summary, our data suggests that lysophosphatidic acid (LPA), a bio‐active
lipid component, enhances lipid accumulation in monocyte‐derived macrophages
during early atherosclerotic plaque formation. In particular, LPA may work through
its G‐protein coupled receptors to initiate the intracellular kinase cascade. Two
pieces of evidence were found: 1) LPA transiently inhibited MAPK activation; 2)
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LPA shortly activated PKD phosphorylation. And next we excluded the possibility
of NF‐B as the downstream transcriptional factors in the LPA‐induced
macrophage activation. Lastly, we observed that scavenger receptors like CD36
and SR‐B1 were up‐regulated in the LPA‐induced macrophages, and the two
scavenger receptors may serve to boost the lipid uptake activity in macrophages.
We believe that the results of our current study form a solid platform for our
future investigation on more detailed cellular signaling pathways and
transcriptional factors that mediate the LPA‐induced macrophage activity which
contribute to the development of vascular disease.
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Table I Scavenger Receptor: ligands and expression profile

Class

A

A

B

SR

ligand relevant to
atherosclerosis

SR‐AI/SR‐AII

oxLDL, acLDL,
malondialdehyde‐LDL,
maleylated LDL
lysophosphatidylcholine
phosphatidic acid
cholesterol
apo A‐I, apo E (Brown
et al.
2007; de Villiers et al.
1994;
Loboda et al. 2006)
glycated type IV
collagen
modified collagen type
I, III and IV
biglycan, decorin (ECM
components)
modified albumin, AGE‐
BSA
beta‐amyloid fibrils
calreticulin, gp 96,
HSP70
family members
(reviewed in
Pluddemann et al.
2007)

Macro

oxLDL > acLDL

CD36

acLDL, oxLDL
VLDL, LDL, HDL
anionic phospholipids
oxidised
phosphatidylserine
oxidised
phosphatidylcholine
long‐chain fatty acids
AGE‐modified proteins
thrombospondin‐I
beta‐amyloid fibrils
(reviewed in Silverstein
and
Febbraio 2009)

Does not bind to

Expression
profile (cell
types)

Expression on
monocytes and
plaque macrophages
in
atherosclerosis

Native LDL, HDL
oxidised
phosphatidylcholine
long‐chain fatty
acids
apo‐SAA
native collagen I
and III
fibrillar collagen I

Myeloid cells
(macrophages,
subpopulations of
DCs) (Horvai et al.
1995)
mast cells (Brown
et al. 2007)
vascular
endothelial cells
(Loboda et al.
2006)
and
smooth muscle
cells within
plaques (Mietus‐
Snyder et al. 2000),
induced by
oxidative
stress

Not on monocytes,
upregulated during
monocyte‐to‐
macrophage
differentiation
(CSF‐1 dependent) (de
Villiers et al. 1994) on
foam cells (Geng et al.
1995; Gough et al. 1999)

Native LDL

Macrophage
subpopulations
(spleen marginal
zone,
medullary lymph
nodes,
resident
peritoneal)
(Karlsson
et al. 2003)

Phosphatidylserine

Macrophages, DCs,
microglia,
platelets
microvascular
endothelial cells
hepatocytes,
adipocytes
cardiac & skeletal
myocytes
breast, kidney, gut
specialized
epithelia
(reviewed in
Silverstein and
Febbraio 2009)
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Upregulated with
progression (PPARgamma
dependent) (Nakagawa‐
Toyama et al. 2001;
Tontonoz et al. 1998)
upregulated during
monocyte‐to‐
macrophage
differentiation (Huh et al.
1996) induced by
atherogenic conditions
including hypertension,
glucose overload and
oxidative stress (Geng et
al. 1994; Griffin et al.
2001; Iwashima et al.
2000)

Table I Scavenger Receptor: ligands and expression profile
Expression profile
(cell types)

Expression on
monocytes and
plaque macrophages
in
atherosclerosis

SR‐BI

acLDL, oxLDL
VLDL, LDL, HDL
anionic phospholipids
oxidised phospholipids
oxidised
phosphatidylcholine
cholesterol

Macrophages
hepatocytes
adrenal gland epithelium
(Terpstra et al. 2000)

CLA‐I (human SR‐BI) low
in
monocytes,
increases with
differentiation
to macrophages
(Chinetti et al.
2000; Hirano et al. 1999;
Svensson et al. 2005)

E

LOX1

oxLDL
Phosphatidylserine
Fibronectin
HSP70

Endothelial cells
induced in macrophages,
smooth muscle cells
(Chen
et al. 2002)

F

SREC‐I/SREC‐II

oxLDL, acLDL
calreticulin, gp 96,
Hsp70

G

SR‐
PSOX/CXCL16

oxLDL
phosphatidylserine

Class

B

H

SR

ligand relevant to
atherosclerosis

Stabilin 1/FEEL‐
1

acLDL
Apoptotic cells
SPARC (Kzhyshkowska
et al.
2005, 2006a,b,c; Park
et al.
2009a,b)

Does not bind
to

acLDL native LDL

Endothelial cells,
macrophages
acLDL native LDL

Native LDL, HDL
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DCs, macrophages
(Shimaoka
et al. 2000)

Sinusoidal endothelial
cells
including spleen,
liver,lymphnode
(Kzhyshkowska et al.
2006a,b,c; Martens et al.
2006)
monocytes/macrophages
(Brocheriou et al. 2011;
Kzhyshkowska et al.
2006a,b,c,
2009)

Upregulated by IL‐4 and
dexamethasone in
human
monocyte‐derived
macrophages
(Kzhyshkowska
et al. 2006a,b,c; Politz et
al.
2002)
Expressed on
CD14(+)CD16(+)
monocytes in patients
with
familial
hypercholesterolemia
(Mosig et al. 2009)
Expressed on
macrophages inhuman
arterial and apoE null
mice atherosclerotic
tissues (Brocheriou et al.
2011)

Table II PCR Primer Pairs Sequence

Primer

Forward Sequence

Reverse Sequence

CXCL2

GCGCCCAGACAGAAGTCATAG

AGGGTCAAGGCAAACTTTTTGA

IL‐1

TGGTTGGCTAACAGCACGTTT

TCGGTCACACGGCCTCTT

Hilpda

GTGCTGGGCATCATGTTGAC

CCTCCCAGAGACTCCATCACTCT

Lamin A

CGCACCGCTCTCATCAACT

TCAGTGAGCGCACCAGCTT

TNF

CAGCCGATGGGTTGTACCTT

GGCAGCCTTGTCCCTTGA

CD14

TCCCGCCCCACCAGAGC

CGGCCAGCGCAGAGCAC

FOS

GCATCGGCAGAAGGGGCAAAGTAG

AGGGGCTCCAGCTCTGTGACCAT

FOSB

AAATGCCCGGCTCCTTCGTG

GGGGGTGCGTCTCGGCTGCTCT

TSP‐1

CAGCATGGTCCTGGAACTGA

CGGATGCTGTCCTGCAGAGT

TG‐2

CCTGCCTGATGCTCTTGGAT

GCAGTCCCGACTACGGTTCTT

Cytohesin1

GGTCCTGCATGCGTTTGTG

AGGCTGGACGAGGTTCAG

Angl‐4

TGCATCCTGGGACGAGATG

CATGGCCGAGCTGTAGCA

C5AR1

AAGGTCTCTCCCCAGCATCA

TCCCTGCCCACTGAATCCT

CD36

GATCGGAACTGTGGGCTCATT

AAAGGCATTGGCTGGAAGAAC

SR‐A

AAAATGGCCCCTCCGTTCAG

ATCCGCCTACACTCCCCTTCTC

SR‐B1

CTGGGTGGCCTTGGGGTTGG

GGGGGCCGTGAAGCGATAC

LPAR1

AGCTGCCTCTACTTCCAGC

TTGCTGTGAACTCCAGCCAG

LPAR2

ATGGGCCAGTGCTACTACAACG

AGGGTGGAGTCCATCAGTG

LPAR3

GACAAGCGCATGGACTTT

CATGTCCTCGTCCTTGTACG

LPAR4

GTTGTATTCATCCTGGGTCT

AGCGACTCCATCCTTATATG

LPAR5

TGCTCTGACCTTGTTGTTCC

AGCAACCCATATACAGCCAGCG
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